HIGHLIGHTS
- who: Xiaoqiang Wang from the Southern Medical University, China have published the research work: Dexmedetomidine ameliorates liver injury and maintains liver function in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study with propensity score matching, in the Journal: (JOURNAL) of July/31,/2020
- how: This retrospective single-center cohort study was conducted in the Eastern Hepatobiliary Surgery Hospital Shanghai China.
- future: The authors included only those patients who granted authorization for future research use of their medical records. It is hard to draw conclusions regarding the effects of DEX on the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.